Business · 02/12/2024Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Anesthetic and Analgesic Drug Products Advisory Committee
Summary
The FDA is hosting a public meeting of the Anesthetic and Analgesic Drug Products Advisory Committee to gather input on a biologics license application for Condoliase Injection, and is seeking public comments on the matter.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →